SIRT1 Protects Against Oxidative Stress-Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation

Journal of Cellular Physiology

Volumn 230, Issue 9, 2015, Pages 2098-2107

  Wang, Yu Qiang ^a   Cao, Qing ^a   Wang, Fei ^a   Huang, Li Ya ^a   Sang, Tian Tian ^a   Liu, Fang ^a   Chen, Shu Yan ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CELL SURFACE MARKER; HYDROGEN PEROXIDE; SELISISTAT; SIRTUIN 1; TRANSCRIPTION FACTOR FKHRL1; ULEX EUROPAEUS AGGLUTININ; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN;

ACETYLATION; APOPTOSIS; ARTICLE; ASSAY; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MORPHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION; UMBILICAL CORD BLOOD; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FETUS BLOOD; GENETICS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ULEX EUROPAEUS;

APOPTOSIS; ENDOTHELIAL PROGENITOR CELLS; FETAL BLOOD; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PROTEOLYSIS; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTIONAL ACTIVATION; UBIQUITINATION;

EID: 84929774382     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24938     Document Type: Article

References (55)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
2. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
3. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015.
4. Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV, Dai Y. 2010. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci 6:599-612.
5. Calnan DR, Brunet A. 2008. The FoxO code. Oncogene 27:2276-2288.
6. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. 2010. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 501:79-90.
7. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, Nakajima T, Fukamizu A. 2004. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101:10042-10047.
8. Donmez G, Guarente L. 2010. Aging and disease: Connections to sirtuins. Aging Cell 9:285-290.
9. Garlanda C, Dejana E. 1997. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17:1193-1202.
10. Goretti E, Rolland-Turner M, Leonard F, Zhang L, Wagner DR, Devaux Y. 2013. MicroRNA-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol 93:645-655.
11. Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H. 2008. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun 372:51-56.
12. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, Zou Y, Bao S, Hanada N, Saso H, Kobayashi R, Hung MC. 2004. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117:225-237.
13. Huang H, Tindall DJ. 2011. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta 1813:1961-1964.
14. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
15. Imai S, Armstrong CM, Kaeberlein M, Guarente L. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403:795-800.
16. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. 2004. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760.
17. Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, Silver M, Li T, Isner JM, Asahara T. 2002. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105:732-738.
18. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422-3427.
19. Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, Accili D. 2005. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2:153-163.
20. Lee SH, Kim JY, Yoo SY, Kwon SM. 2013. Cytoprotective effect of dieckol on human endothelial progenitor cells (hEPCs) from oxidative stress-induced apoptosis. Free Radic Res 47:526-534.
21. Leibiger IB, Berggren PO. 2006. Sirt1: A metabolic master switch that modulates lifespan. Nat Med 12:34-36.
22. Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schachinger V, Lehmann R, Martin H, Burck I, Urbich C, Dimmeler S, Zeiher AM, Assmus B. 2011. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol 100:925-934.
23. Matsuzaki H, Daitoku H, Hatta M, Tanaka K, Fukamizu A. 2003. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci USA 100:11285-11290.
24. Meng S, Cao J, Wang L, Zhou Q, Li Y, Shen C, Zhang X, Wang C. 2012. MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1beta. PLoS One 7:e40323.
25. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. 2005. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Bell 16:4623-4635.
26. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563.
27. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T. 2000. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105:1527-1536.
28. Obsil T, Obsilova V. 2008. Structure/function relationships underlying regulation of FOXO transcription factors. Oncogene 27:2263-2275.
29. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958.
30. Petegnief V, Planas AM. 2013. SIRT1 regulation modulates stroke outcome. Transl Stroke Res 4:663-671.
31. Pickart CM. 2001. Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533.
32. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. 2004. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690-1699.
33. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J, Imaizumi T. 2001. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103:897-903.
34. Sun Y. 2006. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8:645-654.
35. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446.
36. Tang Y, Huang B, Sun L, Peng X, Chen X, Zou X. 2011. Ginkgolide B promotes proliferation and functional activities of bone marrow-derived endothelial progenitor cells: Involvement of Akt/eNOS and MAPK/p38 signaling pathways. Eur Cell Mater 21:459-469.
37. Tang Y, Jacobi A, Vater C, Zou X, Stiehler M. 2014. Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways. Biochem Pharmacol 90:34-49.
38. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. 2002. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786.
39. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, Nguyen K, Rouy D, Altman P, Schwarz R, Mendizabal A, Oskouei B, Byrnes J, Soto V, Tracy M, Zambrano JP, Heldman AW, Hare JM. 2011. Rationale and design of the transendocardial injection of autologous human cells (bone marrow or mesenchymal) in chronic ischemic left ventricular dysfunction and heart failure secondary to myocardial infarction (tac-hft) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 161:487-493.
40. van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM. 2004. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 279:28873-28879.
41. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir Res 89:E1-E7.
42. Wang F, Chan CH, Chen K, Guan X, Lin HK, Tong Q. 2012a. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 31:1546-1557.
43. Wang X, Chen WR, Xing D. 2012b. A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation. J Cell Physiol 227:1168-1178.
44. Wang F, Wang YQ, Cao Q, Zhang JJ, Huang LY, Sang TT, Liu F, Chen SY. 2013a. Hydrogen peroxide induced impairment of endothelial progenitor cell viability is mediated through a FoxO3a dependant mechanism. Microvasc Res 90:48-54.
45. Wang W, Yan C, Zhang J, Lin R, Lin Q, Yang L, Ren F, Zhang J, Ji M, Li Y. 2013b. SIRT1 inhibits TNF-alpha-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis 18:689-701.
46. Wang YQ, Wang F, Deng XQ, Sheng J, Chen SY, Su J. 2013c. Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy. PLoS One 8:e68651.
47. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148.
48. Wu Q, Qi B, Liu Y, Cheng B, Liu L, Li Y, Wang Q. 2013. Mechanisms underlying protective effects of trimetazidine on endothelial progenitor cells biological functions against H2O2-induced injury: Involvement of antioxidation and Akt/eNOS signaling pathways. Eur J Pharmacol 707:87-94.
49. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, Lang JY, Lai CC, Chang CJ, Huang WC, Huang H, Kuo HP, Lee DF, Li LY, Lien HC, Cheng X, Chang KJ, Hsiao CD, Tsai FJ, Tsai CH, Sahin AA, Muller WJ, Mills GB, Yu D, Hortobagyi GN, Hung MC. 2008. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 10:138-148.
50. Yang Y, Hou H, Haller EM, Nicosia SV, Bai W. 2005. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J 24:1021-1032.
51. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, Diehm N, Kalka-Moll W, Baumgartner I, Di Santo S, Kalka C. 2010. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211:103-109.
52. Zampetaki A, Kirton JP, Xu Q. 2008. Vascular repair by endothelial progenitor cells. Cardiovasc Res 78:413-421.
53. Zhang L, Yang R, Han ZC. 2006. Transplantation of umbilical cord blood-derived endothelial progenitor cells: A promising method of therapeutic revascularisation. Eur J Haematol 76:1-8.
54. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP, Liang CC. 2008. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80:191-199.
55. Zhu S, Evans S, Yan B, Povsic TJ, Tapson V, Goldschmidt-Clermont PJ, Dong C. 2008. Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 118:2156-2165.